{"id":17655,"date":"2023-12-20T17:14:12","date_gmt":"2023-12-20T14:14:12","guid":{"rendered":"https:\/\/roboforex.com\/es\/blog\/?p=17655"},"modified":"2024-02-20T18:01:30","modified_gmt":"2024-02-20T15:01:30","slug":"analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir","status":"publish","type":"post","link":"https:\/\/roboforex.com\/es\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/","title":{"rendered":"An\u00e1lisis de las acciones de Pfizer: Tras una ca\u00edda del 50% en dos a\u00f1os: \u00bfes este el momento de invertir?"},"content":{"rendered":"<!DOCTYPE html PUBLIC \"-\/\/W3C\/\/DTD HTML 4.0 Transitional\/\/EN\" \"http:\/\/www.w3.org\/TR\/REC-html40\/loose.dtd\">\n<html><body><p>Las <a href=\"https:\/\/roboforex.com\/es\/forex-trading\/assets\/stocks\/\" data-internallinksmanager029f6b8e52c=\"36\" title=\"invertir acciones\">acciones<\/a> de <a href=\"https:\/\/roboforex.com\/es\/beginners\/info\/charts\/stocks\/PFE\/\" data-internallinksmanager029f6b8e52c=\"164\" title=\"Pfizer Inc\">Pfizer Inc.<\/a> (NYSE: PFE) alcanzaron su m&aacute;ximo de 57,17 d&oacute;lares el 20 de diciembre de 2021, tras lo cual iniciaron un descenso prolongado. El 13 de diciembre de 2023, las cotizaciones alcanzaron un m&iacute;nimo de 25,76 d&oacute;lares, lo que indica una ca&iacute;da del 54,94% en el valor de los t&iacute;tulos de la mayor empresa farmac&eacute;utica en solo dos a&ntilde;os.<\/p>\n\n\n\n<p>Hoy, 18 de diciembre de 2023, analizaremos las razones tras la ca&iacute;da del valor de las acciones de Pfizer Inc. y evaluaremos las perspectivas futuras de la corporaci&oacute;n. Realizaremos un <a href=\"https:\/\/roboforex.com\/es\/beginners\/analytics\/forex-forecast\/technical-analysis\/\" data-internallinksmanager029f6b8e52c=\"8\" title=\"an\u00e1lisis t\u00e9cnico\">an&aacute;lisis t&eacute;cnico<\/a> de las acciones y las previsiones de los expertos en acciones para 2024.<\/p>\n\n\n<input type=\"hidden\" id=\"ays_finish_poll_6\" name=\"ays_finish_poll_6\" value=\"2ba3ba05c8\" \/><input type=\"hidden\" name=\"_wp_http_referer\" value=\"\/es\/blog\/wp-json\/wp\/v2\/posts\/17655\" \/><input type=\"hidden\" id=\"ays_finish_poll_show_res_6\" name=\"ays_finish_poll_show_res_6\" value=\"2ba3ba05c8\" \/><input type=\"hidden\" name=\"_wp_http_referer\" value=\"\/es\/blog\/wp-json\/wp\/v2\/posts\/17655\" \/><style>        #ays-poll-id-6a3796404c38d.box-apm {            width: 100%;                        margin: 0 auto !important;            border-style: none;            border-color: rgba(12,98,145,0);            border-radius: 0;            border-width: 2px;            box-shadow: none;background-color: #edf1f7;            background-position: center center;            background-repeat: no-repeat;            background-size: cover;            max-width: 100%;            position: relative;            padding-bottom: 60px;        }        .ays-poll-id-6a3796404c38d.ays-minimal-theme .apm-choosing{\t\t    display: flex;\t\t    align-items: center;\t\t}        .ays-poll-id-6a3796404c38d div.ays-image-logo-show{\t\t\tposition: absolute;\t\t\tbottom: -5px;    \t\tleft: 1px;\t\t\tmargin: 2px 0 0 0;\t\t\tpadding: 2px;\t\t\twidth: 100%;\t\t\theight: 65px;\t\t\ttext-align: left;\t\t\t\t}        .ays-poll-id-6a3796404c38d .ays-poll-image-logo{\t\t\twidth: 55px;\t\t\theight: 55px;\t\t}\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme .apm-choosing input[type=radio]:checked + label, .ays-poll-id-6a3796404c38d.ays-minimal-theme .apm-choosing label.ays_enable_hover:hover{        \tbackground-color: #000000 !important;\t\t    color: rgba(12,98,145,0) !important;\t\t    border-color: rgba(12,98,145,0) !important;\t\t    font-weight: initial !important;\t\t    margin:3px 0 !important;\t\t}\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme .apm-choosing input[type=radio]:checked + label *,\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme .apm-choosing input[type=checkbox]:checked + label *,\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme .apm-choosing label.ays_enable_hover:hover *{\t\t    color: rgba(12,98,145,0);\t\t}\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme .apm-choosing input[type=radio]{\t\t\t\t\t\tborder-radius: 50%;\t\t\twidth: 20px;\t\t\theight: 19px;\t\t\tmargin: 3px !important;\t\t\tborder: 1px solid #1e8cbe;\t\t\topacity: 1;\t\t}\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme .apm-answers .apm-choosing input[type=radio]:checked::after{\t\t\tcontent: '';\t\t\tborder-radius: 50%;\t\t\twidth: 11px;\t\t\theight: 11px;\t\t\tbackground-color: #1e8cbe;\t\t\t \t\t}\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme .apm-choosing input[type=radio]:focus{\t\t\toutline-offset: 0 !important;    \t\toutline: unset !important;\t\t}\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme .apm-choosing label{\t\t\tborder-color: #000000 !important;\t\t    font-weight: initial !important;\t\t    margin:3px 0 !important;\t\t}\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme .apm-choosing input[type='radio']{\t\t    display: block !important;\t\t}\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme input[type='button'].ays-poll-btn:hover, .ays-poll-id-6a3796404c38d.ays-minimal-theme input[type='button'].ays-poll-btn:focus{\t\t\ttext-decoration: none;\t\t}\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme input[type='button'].ays-poll-btn{\t\t    color: initial !important;\t\t    background: initial !important;\t\t    border: 1px solid #000000;\t\t    border-radius: 3px;\t\t}\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme .ays_poll_passed_count{\t\t    color: #000000 !important;\t\t    background: initial !important;\t\t    border: 1px solid #000000;\t\t    border-radius: 3px;\t\t}\t\t.ays-poll-id-6a3796404c38d.ays-minimal-theme .ays_poll_passed_count i.ays_poll_fa:before{\t\t    color: #000000 !important;\t\t    \t\t}        .ays-poll-id-6a3796404c38d.ays-minimal-theme .answer-percent{        \tcolor: initial !important;\t\t}        .ays-poll-id-6a3796404c38d.box-apm span.ays_poll_passed_count{            background-color: #000000;            color: #edf1f7;        }        #ays-poll-id-6a3796404c38d.box-apm span.ays_poll_passed_count i{            color: #edf1f7;        }        #ays-poll-id-6a3796404c38d.box-apm .apm-title-box{            background-color: rgba(255,255,255,0);        }        .ays-poll-id-6a3796404c38d .answer-percent {            background-color: rgba(12,98,145,0);            color: #edf1f7 !important;        }        .ays-poll-id-6a3796404c38d .ays-poll-btn{            color: rgba(251,254,249,0) !important;            background-color: rgba(12,98,145,0) !important;            overflow: hidden;        }        #ays-poll-id-6a3796404c38d .ays-poll-view-more-button{\t\t    border-radius: 0;\t\t}        .ays-poll-id-6a3796404c38d.box-apm * {            color: #000000;        }        .ays-poll-id-6a3796404c38d.box-apm .apm-title-box div {            color: #000000;            text-transform: inherit;            font-family: inherit;\t\t\t        }        #ays-poll-id-6a3796404c38d.box-apm i {            color: rgba(12,98,145,0);            font-size: 24px;            font-style: normal;                    }\t\t#ays-poll-id-6a3796404c38d .ays-poll-btn{       \t\twidth: auto;\t\t\tfont-size: 17px;\t\t\tpadding: 10px 20px;\t\t\tborder-radius: 3px;\t\t\tcolor: rgba(251,254,249,0) !important;\t\t\tbackground: rgba(12,98,145,0) !important;\t\t\tborder: none;\t\t\tline-height: 12px !important;\t\t}\t\t#ays-poll-id-6a3796404c38d .apm-add-answer input.ays-poll-new-answer-apply-text{            width: 100%;\t\t\tmargin-bottom: 0;\t\t\tmargin-right: 5px;\t\t\tborder-color: rgba(12,98,145,0); \t\t\tpadding: 7px;\t\t\tfont-size: 14px;\t\t\tcolor: black;\t\t\theight: 40px; \t\t\toutline: none;\t\t\tdisplay: inline-block;        }        #ays-poll-id-6a3796404c38d.box-apm i.ays_poll_far{                        font-family: 'Font Awesome 5 Free';        }        #ays-poll-id-6a3796404c38d.box-apm .apm-choosing .ays-poll-each-answer-list{            \t\t\twidth: initial;\t\t\ttext-align: initial;\t\t\tdisplay: initial;\t\t\tpadding: 10px;        }        #ays-poll-id-6a3796404c38d.box-apm .apm-choosing .ays-poll-each-answer-grid{            \t\t\twidth: 100%;\t\t\ttext-align: left;\t\t\tdisplay: inline-block;\t\t\tword-break: break-word;        }\t\t        #ays-poll-id-6a3796404c38d.box-apm .apm-choosing .ays_label_poll{            \t\t\twidth: 100%;\t\t\ttext-align: center;\t\t\tdisplay: flex;\t\t\t;\t\t\talign-items: center;\t\t\tpadding: 10px;        }        #ays-poll-id-6a3796404c38d.box-apm .apm-choosing .ays-poll-each-image{            \t\t\theight: 150px;\t\t\tborder-radius: 0px;\t\t\tobject-fit: cover;        }        #ays-poll-id-6a3796404c38d.box-apm .apm-choosing .ays-poll-each-image-list{\t\t\twidth: 220px;        }        #ays-poll-id-6a3796404c38d.box-apm .apm-choosing .ays-poll-each-image-grid{\t\t\twidth: 100%;        }        #ays-poll-id-6a3796404c38d.box-apm .apm-choosing .ays-poll-answer-container-label-grid{\t\t\talign-items: center;        }        #ays-poll-id-6a3796404c38d.box-apm .apm-choosing .ays-poll-answer-container-label-list{\t\t\tflex-direction: row;        }        #ays-poll-id-6a3796404c38d.box-apm .ays_poll_grid_view_container{\t\t\tdisplay: flex;\t\t\tflex-wrap: wrap;\t\t\tjustify-content: space-between;\t\t\talign-items: flex-start;        }        #ays-poll-id-6a3796404c38d.box-apm .ays-poll-answer-container-gird{\t\t\twidth: calc(50% - 5px);\t\t\tmargin-bottom: 1px;        }\t\t        #ays-poll-id-6a3796404c38d.box-apm .ays_poll_label_without_padding{\t\t\tpadding: 10px;\t\t\talign-items: center;\t\t\tflex-direction: column;        }        #ays-poll-id-6a3796404c38d.box-apm .apm-title-box div{\t\t\tfont-size: 20px;\t\t\tword-break: break-word;\t\t\tword-wrap: break-word;\t\t\ttext-align: left;        }        #ays-poll-id-6a3796404c38d.box-apm .ays-poll-answer-container-list{\t\t\t\t\t\tmargin-bottom: 1px;\t\t\tdisplay: flex;\t\t\twidth: 100%;        }        #ays-poll-id-6a3796404c38d.box-apm .ays-poll-maker-text-answer-main input,\t\t#ays-poll-id-6a3796404c38d.box-apm .ays-poll-maker-text-answer-main textarea{\t\t\tmin-width: 150px;\t\t\tmax-width: 100%;\t\t\twidth: %;        }        #ays-poll-id-6a3796404c38d.box-apm .ays-poll-password-box .ays-poll-password-button-box .ays-poll-password-button{\t\t\tbackground-color: rgba(12,98,145,0);\t\t\tcolor: #edf1f7;\t\t\tborder-color: rgba(12,98,145,0);\t\t\toutline: none;\t\t\tbox-shadow: unset;\t\t\tborder: 0;\t\t\ttransition: .5s;        }        #ays-poll-id-6a3796404c38d.box-apm .ays-poll-password-box .ays-poll-password-button-box .ays-poll-password-button:hover{\t\t\tbackground-color: rgba(12,98,145,0)b5;        }        #ays-poll-id-6a3796404c38d.box-apm .ays-poll-password-box .ays-poll-password-input-box .ays-poll-password-input{\t\t\tborder-color: rgba(12,98,145,0);        }\t\t#ays-poll-id-6a3796404c38d.box-apm .apm-answers .apm-choosing label.ays_label_poll{            \t\t\tbox-shadow:unset;\t\t\tborder-radius: 0px;        }\t\t#ays-poll-id-6a3796404c38d.box-apm.text-poll .apm-answers .ays-poll-text-types-inputs{            \t\t\tfont-size: 16px;        }\t\t\t\t\t#ays-poll-id-6a3796404c38d div.apm-load-message-container{            \t\t\t\tbackground-color: #edf1f7 !important;\t\t\t}        .ays-poll-id-6a3796404c38d.choosing-poll input[type=radio]:checked + label,\t\t.ays-poll-id-6a3796404c38d:not(.ays-minimal-theme).choosing-poll input[type='checkbox']:checked + label,        .ays-poll-id-6a3796404c38d.choosing-poll label.ays_enable_hover:hover {        \tbackground-color: #000000 !important;            color: #edf1f7;        }\t\t.ays-poll-id-6a3796404c38d:not(.ays-minimal-theme).choosing-poll input[type='checkbox']{\t\t\tdisplay: none;\t\t}        .ays-poll-id-6a3796404c38d.choosing-poll input[type=radio]:checked + label *,        .ays-poll-id-6a3796404c38d.choosing-poll input[type=checkbox]:checked + label *,        .ays-poll-id-6a3796404c38d.choosing-poll label.ays_enable_hover:hover * {            color: #FBFEF9;        }\t\t   #ays-poll-id-6a3796404c38d.choosing-poll label.ays_label_poll:not(.apm-label-with-bg) span.ays_grid_answer_span{\t\t\t   display: inline-block;\t\t\t   width: calc(100% - 10px);\t\t\t   margin: 0 -15px;\t\t\t}\t\t   #ays-poll-id-6a3796404c38d.choosing-poll label.ays_label_poll span.ays_grid_answer_span{\t\t\t   display: inline-block;\t\t\t   width: calc(100% - 10px);\t\t\t}#ays-poll-id-6a3796404c38d label.ays_poll_answer_icon_radio:before,\t\t#ays-poll-id-6a3796404c38d label.ays_poll_answer_icon_checkbox:before{\t\t\tcontent: '';\t\t\tdisplay: inline-block;\t\t\tbackground: #ddd;\t\t\tbackground-clip: content-box;\t\t\twidth: 20px;\t\t\theight: 20px;\t\t\tborder: 3px solid #ccc;\t\t\tpadding: 3px 3px 3px 3px;\t\t\tbox-sizing: border-box;\t\t\ttransition: all .4s linear;\t\t\tvertical-align: middle;\t\t\tmargin-right: 10px;\t\t\tmargin-bottom: 2px;\t\t}\t\t#ays-poll-id-6a3796404c38d label.ays_poll_answer_icon[for='poll_answer_icon_radio']:before,\t\t#ays-poll-id-6a3796404c38d label.ays_poll_answer_icon_radio:before{\t\t\tborder-radius: 50%;\t\t}\t\t#ays-poll-id-6a3796404c38d input[name='answer']:checked + label.ays_poll_answer_icon_radio:before,\t\t#ays-poll-id-6a3796404c38d input[name='answer']:checked + label.ays_poll_answer_icon_checkbox:before{\t\t\tbackground: green;\t\t\tborder: 3px solid green;\t\t\tpadding: 3px 3px 3px 3px;\t\t\tbackground-clip: content-box;\t\t\tbackground-color: green !important;\t\t}.ays-poll-id-6a3796404c38d .apm-info-form input {            border-color: rgba(12,98,145,0);        }        div[class~=ays-poll-id-6a3796404c38d] label.ays_label_font_size {            font-size: 16px;        }        button.ays-poll-next-btn:focus {            background: unset;            outline: none;        }        button.ays-poll-next-btn:disabled {            cursor: not-allowed;            background: dimgrey !important;            color: white !important;        }        button.ays-poll-next-btn:enabled {            cursor: pointer;        }        .ays-poll-id-6a3796404c38d .apm-info-form input {            color: #000000 !important;            background-color: #FBFEF9 !important;        }         .ays-poll-main #ays-poll-id-6a3796404c38d .ays-poll-img {            object-fit: cover;\t\t\theight: 100%;         }        .ays-poll-id-6a3796404c38d div.apm-loading-gif .apm-loader svg path,        .ays-poll-id-6a3796404c38d div.apm-loading-gif .apm-loader svg rect {            fill: rgba(12,98,145,0);        }body .ays-poll-main {\tmax-width: 100%;}.box-apm {\tpadding: 27px 30px 16px 32px!important;\t\/* display: flex; *\/\t\/* flex-wrap: wrap; *\/}.box-apm .ays_poll_cb_and_a {    display: none !important;}.apm-title-box h5 {\tfont-family: \"Roboto Slab\",serif!important;\tcolor: #2E3A59!important;\tfont-weight: 500;}.box-apm .apm-choosing.ays-poll-field.ays-poll-answer-container-gird {    max-width: 146px !important;    margin-top: 3px !important;}.apm-choosing.answer-ays-poll-id-64ccfb3155075.ays-poll-field.ays-poll-answer-container-gird {}.button-main {    font-size: 16px;    line-height: 44px;    color: #fff !important;    font-weight: 400;    background-color: #1378bf;    border: 0;    min-height: 44px;    text-align: center;    cursor: pointer;    outline: 0;    transition: background-color .2s,box-shadow .2s;    display: inline-block;    border-radius: 8px;    transform: translateZ(0);    margin: 0px 10px 0 10px;    padding: 0 10px;    min-width: 144px;}.button-main:hover {    background-color: #3592d3;\t}.button-outlined {    font-weight: 400;    font-size: 16px;    line-height: 44px;    background-color: transparent;    border: 2px solid rgba(143, 155, 179, 0.5);    height: 44px;    padding: 6px 15px !important;    display: -ms-inline-flexbox;    display: inline-flex;    -ms-flex-align: center;    align-items: center;    -ms-flex-pack: center;    justify-content: center;    border-radius: 8px;    cursor: pointer;    outline: 0;    transition: background-color .3s;    color: #2E3A59 !important;    width: 144px;}.button-outlined:hover {\tborder: 2px solid rgba(143, 155, 179, 1);}.results-apm {    display: flex;    position: relative;    max-width: 228px;    width: 100%;    float: left;    padding: 0;    margin-top: 30px !important;}.answer-title.flex-apm {    position: absolute;}.results-apm > div:first-child {    left: 0;    top: -20px;    color: #8F9BB3;\tfont-size: 13px;}.results-apm span.ays_check:before {\tdisplay: none;}.results-apm > div:nth-child(2) {\tcolor: #2E3A59 !important;\tborder-radius: 5px 0 0 5px !important;\ttext-align: left !important;\tbackground: transparent linear-gradient(281deg, #A0FFD7 0%, #15B773 100%) 0% 0% no-repeat padding-box;\tmargin-right: 2px;\tfont-size: 13px !important;\tfont-weight: 500;\tline-height: 44px !important;\theight: 8px !important;}.results-apm > div:nth-child(3) {    right: 0px;    top: -20px;    color: #8F9BB3;\tfont-size: 13px;}.results-apm > div:nth-child(4) {    background: transparent linear-gradient(79deg, #FFBEC0   0%, #ED1C24 100%) 0% 0% no-repeat;    color: #2E3A59 !important;    border-radius: 0 5px 5px 0 !important;    text-align: right !important;    margin-left: 2px;    font-size: 13px !important;    font-weight: 500;    line-height: 44px !important;    height: 8px !important;}label.ays_poll_answer_icon_checkbox::before {    padding: 0 !important;    background-size: 100% !important;    border: none !important;    background-color: transparent !important;}span.answer-text {    font-size: 13px;    line-height: 16px;    color: #8F9BB3 !important;}.ays_res_mess {\tfloat: right;}.box-apm .apm-title-box.ays_res_mess {\tmargin-top: 12px !important;\tmargin-bottom: 20px !important;\torder: 9;}.ays-poll-main .box-apm > div {\t\/* margin-top: -5px !important; *\/\tmargin-bottom: 11px;\tmargin-top: 0;}\/* upd *\/.choosing-poll .instrument-poll {    position: relative;    font-weight: 500;    font-size: 32px;    line-height: 53.8px;    padding-left: 38px;    font-family: \"Roboto Slab\",serif!important;    color: #2E3A59 !important;\tbackground-color: #edf1f7;}body #primary .apm-answers.apm-answers-without-submit.ays_poll_grid_view_container:before {    content: \"-\";    position: absolute;    display: block;    height: 46px;    width: 129px;    left: 1px;    top: 1px;    background-size: 24px 24px;    background-position-x: 0px;    background-position-y: 17px;    background-image: url(\/wp-content\/uploads\/2023\/10\/lines.png);    background-repeat: no-repeat;    font-weight: 500;    font-size: 32px;    line-height: 53.8px;    padding-left: 38px;    font-family: \"Roboto Slab\",serif!important;    color: #2E3A59 !important;}body #primary .apm-answers.apm-answers-without-submit.ays_poll_grid_view_container {    position: relative;}body #primary .apm-answers.apm-answers-without-submit.ays_poll_grid_view_container:after {    content: \"\";    position: absolute;    display: block;    height: 27px;    width: 25px;    left: calc(50% - 82px);    top: 14px;    background-size: contain;    background-image: url('\/wp-content\/uploads\/2023\/10\/arrows.png');    background-repeat: no-repeat;}\/* #primary .ays-poll-main::before {  content: \"\";  display: block;  position: absolute;  top: 0;  left: 35px;  right: 0;  bottom: 0;  z-index: 999;  width: 50px;  height: 50px;   animation: spinAndFadeOut 3s forwards;  border: 4px solid #3498db;  border-top: 4px solid transparent;  border-radius: 50%;}@keyframes spinAndFadeOut {  0% {    transform: rotate(0deg);    opacity: 1;  }  90% {    transform: rotate(360deg);    opacity: 1;  }  100% {    transform: rotate(360deg);    opacity: 0;    display: none;  }} *\/.choosing-poll .instrument-poll:before {    content: \"\";    position: absolute;    display: block;    height: 27px;    width: 25px;    left: 1px;    top: 18px;    background-size: contain;    background-image: url('\/wp-content\/uploads\/2023\/10\/lines.png');    background-repeat: no-repeat;}.choosing-poll .apm-choosing {    max-width: 180px;    border-radius: 8px;    border: 2px solid #8F9BB380;    text-align: center;    align-self: start;}.choosing-poll .apm-choosing:nth-last-child(2) {    margin-left: auto;}.choosing-poll .apm-choosing .ays_label_poll {    justify-content: center;    padding: 9px 10px 4px 4px!important;}.choosing-poll .apm-choosing .ays_label_poll .ays-poll-each-answer-grid {    font-weight: 400;    font-size: 16px;}.choosing-poll .apm-choosing:last-child label.ays_poll_answer_icon_checkbox::before {    background-image: url('\/wp-content\/uploads\/2023\/10\/arrow-down.png') !important;}.choosing-poll .apm-choosing label.ays_poll_answer_icon_checkbox::before {    background-image: url('\/wp-content\/uploads\/2023\/10\/arrow-up.png') !important;}.ays-poll-id-64ccfab5cef3a.choosing-poll input[type=radio]:checked + label, .ays-poll-id-64ccfab5cef3a .choosing-poll input[type='checkbox']:checked + label, .apm-choosing.answer-ays-poll-id-64ccfb3155075.ays-poll-field.ays-poll-answer-container-gird:hover {    outline: 5px solid #1378bf!important;    outline-offset: -4px!important;    border-radius: 30px !important;    background-color: #1378bf !important;    color: #ffffff !important;}label.ays_label_poll.disable_hover.ays_label_font_size.ays_poll_answer_icon_checkbox.ays-poll-answer-container-label-grid:hover .ays-poll-each-answer-grid,label.ays_label_poll.disable_hover.ays_label_font_size.ays_poll_answer_icon_checkbox.ays-poll-answer-container-label-grid:checked .ays-poll-each-answer-grid {    color: #fff;}.apm-answers.apm-answers-without-submit.ays_poll_grid_view_container {    position: relative;    column-gap: 50px;}.apm-answers.apm-answers-without-submit.ays_poll_grid_view_container {    column-gap: 10px !important;}body #primary  .box-apm {\tpadding-left: 0;\tpadding-right: 0;\t\tborder-radius: 24px;}body #primary .choosing-poll input[type=radio]:checked + label, body #primary  .choosing-poll label.ays_enable_hover:hover {    background-color:  #1378BF !important;    border-radius: 8px !important;    outline: 5px solid #1378bf!important;    outline-offset: -3px!important;}body #primary .apm-answers.apm-answers-without-submit.ays_poll_grid_view_container {\talign-items: center;\tmargin-top: 19px !important;\tmargin-bottom: 3px;\twidth: 100%;}body #primary .sentiment__bl {    align-items: center !important;}body #primary .sentiment__bl.sentiment__memory {\tmargin-right: 22px !important;}body #primary .sentiment__bl.sentiment__memory .js-vote-bear {\tfont-size: 13px !important;\tmargin-bottom: 5px !important;}body #primary .sentiment__bl div {\tmargin: 0 5px 0 5px;}@media (max-width: 1280px) {\tbody #primary .box-apm .apm-title-box h5 {\t\ttext-align: left;\t}    .results-apm,body #primary  .ays_res_mess{        \/* display: block; *\/        width: 100%;        max-width: 100%;    }\tbody #primary  .sentiment__row.custom-answer {    justify-content: center;\t}\t.box-apm .apm-title-box.ays_res_mess {\t\torder: 9;\t}}@media (max-width: 768px) {.choosing-poll .instrument-poll {\tgrid-area: 1 \/ 1 \/ 2 \/ 3;}\t\t.box-apm {\tpadding: 26px 22px !important;}\tbody #primary .apm-answers.apm-answers-without-submit.ays_poll_grid_view_container:after {\t\tcontent: none;\t}    body #primary .apm-answers.apm-answers-without-submit.ays_poll_grid_view_container {        row-gap: 15px;        display: grid;        grid-template-columns: repeat(2, 1fr);        grid-template-rows: 50px 1fr;        margin-top: 9px !important;    }    body #primary .choosing-poll .apm-choosing {        max-width: 100% !important;        width: 100% !important;    }\tbody #primary .choosing-poll .apm-choosing:nth-last-child(2) {\t\tgrid-area: 2 \/ 1 \/ 3 \/ 2;\t}\tbody #primary .choosing-poll .apm-choosing:nth-last-child(1) {\t\tgrid-area: 2 \/ 2 \/ 3 \/ 3;\t}}\t\t\t@media (max-width: 1280px) {.box-apm {\tdisplay: flex;\tflex-wrap: wrap;}    body #primary .button-outlined,    body #primary .button-main{        \/* display: flex;        align-items: center;        white-space: nowrap;        font-size: 14px; *\/        \/* min-width: 140px; *\/    }    body #primary .sentiment__bl.sentiment__memory {        display: none !important;    }    body #primary .sentiment__row.custom-answer {    width: 100%;    box-sizing: border-box;    }\tbody #primary .sentiment__bl {\t\twidth: 100%;\t\tcolumn-gap: 12px;\t\tbox-sizing: border-box;\t}\tbody #primary .sentiment__bl div {\t\twidth: 50%;\t\tmargin: 0;\t\tbox-sizing: border-box;\t}   body #primary .ays_res_mess {        margin-top: 0;        margin-bottom: -3px !important;    }\tbody #primary .results-apm {\t\tmargin-top: 35px !important;\t\tmargin-bottom: 13px  !important;}    body #primary .box-apm .apm-title-box h5 {        line-height: 1.2;    }\tbody #primary div#ays-poll-container-13 {    margin: 0 !important;    max-width: 100%;}}@media (max-width: 420px) {    body #primary .sentiment__bl div {        font-size: 12px;        white-space: nowrap;    }    .button-main {        min-width: auto;    }}.ays-poll-id-6a3796404c38d div.apm-loading-gif .apm-loader{\t\t\t\tdisplay: flex;\t\t\t\tjustify-content: center;\t\t\t\talign-items: center;\t\t\t\tpadding-top: 10px;\t\t\t}\t\t\t.ays-poll-id-6a3796404c38d div.apm-loading-gif{\t\t\t\twidth: 100%;    \t\t\theight: 100%;\t\t\t}\t\t\t.ays-poll-id-6a3796404c38d.box-apm .ays_question p{\t\t\tfont-size: 16px;\t\t}\t\t\t\t@media only screen and (max-width: 768px){\t\t\t#ays-poll-id-6a3796404c38d.box-apm {\t\t\t\twidth: 100%;\t\t\t}\t\t\t#ays-poll-id-6a3796404c38d.box-apm .ays-poll-btn{\t\t\t\twidth: auto;\t\t\t}\t\t\t.ays-poll-id-6a3796404c38d.box-apm .ays_question p{\t\t\t\tfont-size: 16px;\t\t\t}\t\t\t\t\t\t.ays-poll-id-6a3796404c38d .apm-answers .apm-rating i.ays_poll_fa-star {\t\t\t\tfont-size: 4vw !important;\t\t\t}\t\t\t#ays-poll-id-6a3796404c38d.box-apm .ays-poll-answer-container-gird{\t\t\t\twidth: 100%;\t\t\t}\t\t\t#ays-poll-id-6a3796404c38d.box-apm .apm-title-box div{\t\t\t\tfont-size: 20px;\t\t\t\ttext-align: left;\t\t\t\tword-break: break-word;\t\t\t\tword-wrap: break-word;\t\t\t}\t\t\t.ays-poll-id-6a3796404c38d.box-apm label.ays_label_font_size {\t\t\t\tfont-size: 16px;\t\t\t}\t\t\t#ays-poll-id-6a3796404c38d.box-apm.text-poll .apm-answers .ays-poll-text-types-inputs{            \t\t\t\tfont-size: 16px;\t\t\t}\t\t\t#ays-poll-id-6a3796404c38d.box-apm .apm-answers > .apm-choosing > .ays_label_poll > div.ays-poll-answer-image > img.ays-poll-each-image{\t\t\t\theight: 150px;\t\t\t}\t\t\t#ays-poll-id-6a3796404c38d.box-apm .apm-answers .apm-choosing > label.ays-poll-answer-container-label-list > p.ays-poll-answers > span.ays-poll-each-answer-list {\t\t\t\tpadding: unset;\t\t\t\tword-wrap: break-word;\t\t\t}\t\t\t#ays-poll-id-6a3796404c38d .ays-poll-btn{\t\t\t\tfont-size: 17px;\t\t\t\tline-height: 1;\t\t\t\twhite-space: normal;\t\t\t\tword-break: break-word;\t\t\t}\t\t}\t\t@media screen and (max-width: 768px){\t\t\t#ays-poll-id-6a3796404c38d{\t\t\t\tmax-width: 100%;\t\t\t}\t\t}\t\t#ays-poll-container-6{        \twidth: 100%;\t\t}\t\t@media screen and (max-width: 768px){\t\t\t#ays-poll-container-6{\t\t\t\twidth: 100%;\t\t\t\tmax-width: 96%;\t\t\t}\t\t\t#ays-poll-id-6a3796404c38d.box-apm .apm-choosing .ays-poll-each-image-list{\t\t\t\twidth: 100%;        \t}\t\t}\t\t\t           <\/style>        <script>            var dataCss = {\t\t\t\twidth: '100%',                maxWidth: '98%',                fontSize: '16px',                padding: '10px',                margin: '0 auto',                marginTop: '-1rem',                borderStyle: 'none',                borderWidth: '2px',                borderColor: 'rgba(12,98,145,0)',                background: '#edf1f7',                color: 'rgba(12,98,145,0)',                transition: '.3s ease',                WebkitAppearance: 'none',                appearance: 'none',                };            var hoverCss = {                background: 'rgba(12,98,145,0)',                color: '#edf1f7',                borderColor: '#edf1f7',            };        <\/script><div style='margin-bottom: 1rem;' class='ays-poll-main PFE' id='ays-poll-container-6' data-load-method='1'>        <form style='margin-bottom: 0;' >                        <div                dir='ltr'        data-loading='blur'        data-load-gif=''        data-load-gif-font-size='64'                data-hide-bg-image='true'        data-gradient-check=''        data-gradient-dir='to bottom'        data-gradient-c1='#103251'        data-gradient-c2='#607593'        data-hide-bg-image-def-color='#edf1f7'        data-show-social=''        class='box-apm  choosing-poll ays-poll-id-6a3796404c38d '        id='ays-poll-id-6a3796404c38d'        data-res='0'        data-res-sort='none'        data-restart ='false'        data-redirection = '0'        data-redirect-check = '0'        data-url-href = ''        data-href = ''        data-delay = '0'        data-id='6'        data-res-rgba = ''        data-percent-color = '#0c6291'        data-enable-top-animation = ''        data-top-animation-scroll = '100'        data-info-form=''        data-enable-social-links=''        ><div class='ays_poll_cb_and_a'><\/div><div class='apm-title-box'><div>\u00bfCu\u00e1l es su opini\u00f3n sobre Pfizer Inc.?<\/div><\/div><div class='ays-poll-id-6a3796404c38d ays_question'><\/div><div class='ays-poll-id-6a3796404c38d hideResults ays-poll-hide-result-box'> <\/div><div class='apm-answers apm-answers-without-submit ays_poll_grid_view_container'>\t\t\t\t\t\t\t\t\t\t\t<div class='apm-choosing answer-ays-poll-id-6a3796404c38d  ays-poll-field ays-poll-answer-container-gird' >\t\t\t\t\t\t\t\t\t\t\t<input type=radio name='answer' id='radio-0-ays-poll-id-6a3796404c38d' value='14' autocomplete=\"off\">\t\t\t\t\t\t\t\t\t\t\t<label \t\t\t\t\t\t\t\t\t\t\t\tfor='radio-0-ays-poll-id-6a3796404c38d' \t\t\t\t\t\t\t\t\t\t\t\tclass='ays_label_poll   ays_enable_hover ays_label_font_size ays_poll_answer_icon_checkbox  ays-poll-answer-container-label-grid' \t\t\t\t\t\t\t\t\t\t\t\tdata-answers-url=''\t\t\t\t\t\t\t\t\t\t\t> <p style='' class='ays-poll-answers'><span class='ays-poll-each-answer-grid'>Alcista<\/span><\/p><\/label>\t\t\t\t\t\t\t\t\t\t\t<\/div>\t\t\t\t\t\t\t\t\t\t\t<div class='apm-choosing answer-ays-poll-id-6a3796404c38d  ays-poll-field ays-poll-answer-container-gird' >\t\t\t\t\t\t\t\t\t\t\t<input type=radio name='answer' id='radio-1-ays-poll-id-6a3796404c38d' value='15' autocomplete=\"off\">\t\t\t\t\t\t\t\t\t\t\t<label \t\t\t\t\t\t\t\t\t\t\t\tfor='radio-1-ays-poll-id-6a3796404c38d' \t\t\t\t\t\t\t\t\t\t\t\tclass='ays_label_poll   ays_enable_hover ays_label_font_size ays_poll_answer_icon_checkbox  ays-poll-answer-container-label-grid' \t\t\t\t\t\t\t\t\t\t\t\tdata-answers-url=''\t\t\t\t\t\t\t\t\t\t\t> <p style='' class='ays-poll-answers'><span class='ays-poll-each-answer-grid'>Bajista<\/span><\/p><\/label>\t\t\t\t\t\t\t\t\t\t\t<\/div><\/div><div class='apm-cashed-fa'><div>                                <i class='ays_poll_fas ays_poll_fa-star' style='font-size: 0'><\/i>                            <\/div><div>                                <i class='ays_poll_fas ays_poll_fa-star' style='font-size: 0'><\/i>                            <\/div><\/div><input type=\"hidden\" id=\"ays_finish_poll_show_res_6\" name=\"ays_finish_poll_show_res_6\" value=\"2ba3ba05c8\" \/><input type=\"hidden\" name=\"_wp_http_referer\" value=\"\/es\/blog\/wp-json\/wp\/v2\/posts\/17655\" \/><div class='apm-button-box'><input type='button' \t                    name='ays_finish_poll'\t                    class='btn ays-poll-btn choosing-btn ays_finish_poll'\t                    data-form='ays-poll-id-6a3796404c38d'\t                    value=\"Votar\"\t                    ><\/div><div class='apm-title-box ays_res_mess'> <\/div><script>\t\t\t\tif(typeof aysPollOptions === 'undefined'){\t\t\t\t\tvar aysPollOptions = [];\t\t\t\t}\t\t\t\taysPollOptions['ays-poll-id-6a3796404c38d']  = '{"main_color":"rgba(12,98,145,0)","text_color":"#000000","button_text_color":"rgba(251,254,249,0)","button_bg_color":"rgba(12,98,145,0)","icon_color":"rgba(12,98,145,0)","bg_color":"#edf1f7","bg_image":"","enable_answer_style":"off","answer_bg_color":"#FBFEF9","answer_border_side":"all_sides","answer_font_size":"16","poll_answer_font_size_mobile":"16","poll_answer_object_fit":"cover","poll_answer_padding":"10","poll_answer_margin":"10","poll_answer_border_radius":0,"poll_answer_icon_check":"on","poll_answer_icon":"checkbox","poll_answer_view_type":"grid","poll_answer_enable_box_shadow":"off","poll_answer_box_shadow_color":"#000000","poll_answer_box_shadow_x_offset":0,"poll_answer_box_shadow_y_offset":0,"poll_answer_box_shadow_z_offset":10,"title_bg_color":"rgba(255,255,255,0)","poll_title_font_size":"20","poll_title_font_size_mobile":"20","icon_size":24,"width":0,"width_for_mobile":0,"poll_min_height":"","border_style":"none","border_radius":"0","border_width":"2","border_color":"rgba(12,98,145,0)","enable_box_shadow":"off","box_shadow_color":"#000000","poll_box_shadow_x_offset":0,"poll_box_shadow_y_offset":0,"poll_box_shadow_z_offset":15,"enable_background_gradient":"off","background_gradient_color_1":"#103251","background_gradient_color_2":"#607593","poll_gradient_direction":"vertical","poll_question_size_pc":"16","poll_question_size_mobile":"16","poll_question_image_height":"","poll_question_image_object_fit":"cover","poll_mobile_max_width":"","poll_buttons_size":"medium","poll_buttons_font_size":"17","poll_buttons_mobile_font_size":"17","poll_buttons_left_right_padding":"20","poll_buttons_top_bottom_padding":"10","poll_buttons_border_radius":"3","poll_buttons_width":"","disable_answer_hover":0,"logo_image":"","poll_enable_logo_url":"off","poll_logo_title":"","poll_logo_url":"","custom_class":"PFE","enable_poll_title_text_shadow":"off","poll_title_text_shadow":"rgba(255,255,255,0)","poll_title_text_shadow_x_offset":2,"poll_title_text_shadow_y_offset":2,"poll_title_text_shadow_z_offset":0,"poll_allow_multivote":"off","multivote_answer_min_count":"1","poll_allow_multivote_count":"1","poll_direction":"ltr","show_create_date":0,"show_author":0,"active_date_check":"","activeInterval":"2023-10-26","activeIntervalSec":"","deactiveInterval":"2023-10-26","deactiveIntervalSec":"","ays_poll_show_timer":0,"ays_show_timer_type":"countdown","show_result_btn_see_schedule":"with_see","active_date_message_soon":"<p style=\\\"text-align: center;\\\">The poll will be available soon!<\/p>\n","active_date_message":"<p style=\\\"text-align: center;\\\">The poll has expired!<\/p>\n","show_result_btn_schedule":0,"dont_show_poll_cont":"off","allow_not_vote":0,"see_res_btn_text":"See Results","enable_pass_count":null,"redirect_users":0,"redirect_after_vote_url":false,"redirection_delay":0,"randomize_answers":"off","enable_asnwers_sound":"off","poll_vote_reason":"off","enable_vote_btn":0,"btn_text":"Vote","enable_view_more_button":"off","poll_view_more_button_count":0,"answer_sort_type":"default","show_answers_numbering":"none","hide_results":0,"hide_result_message":1,"hide_results_text":"<p style=\"text-align: center;\">Thanks for your answer!<\/p>","result_message":"<div class=\"sentiment__row custom-answer\" style=\"display: flex; align-items: center;\">\r\n<div class=\"sentiment__bl sentiment__memory\" style=\"margin-right: 10px;\">\r\n<div>\r\n<p class=\"js-vote-bull hidden\" style=\"color: #2e3a59; font-size: 13px; font-weight: 500; line-height: 18px; text-align: left;\">Ha votado <strong>Alcista<\/strong><\/p>\r\n<p class=\"js-vote-bear\" style=\"color: #2e3a59; font-size: 13px; font-weight: 500; line-height: 18px; text-align: left;\">Ha votado <strong>Bajista<\/strong><\/p>\r\n<p style=\"color: #8f9bb3; font-size: 13px; line-height: 18px; text-align: left; visibility: hidden; height: 0;\">Give a try<\/p>\r\n<\/div>\r\n<\/div>\r\n<div class=\"sentiment__bl\" style=\"display: flex;\">\r\n<div class=\"button-main rounded js_signup_new js-analyticsClick\" data-link=\"uu\" data-type=\"bullBearWidget_trade\">Empezar a operar<\/div>\r\n<div class=\"button-outlined rounded js_signup js-analyticsClick\" data-link=\"uu\" data-type=\"bullBearWidget\" data-demomode=\"true\">Probar demo<\/div>\r\n<\/div>\r\n<\/div>\r\n","show_social":0,"poll_social_buttons_heading":"","poll_show_social_ln":"on","poll_show_social_fb":"on","poll_show_social_tr":"on","poll_show_social_vk":"off","load_effect":"blur","load_gif":"plg_default","limit_users":1,"limit_users_method":"cookie_ip","limitation_message":"<p style=\\\"text-align: left;font-size: 16px;color: #8F9BB3;\\\">Ya ha votado usted<\/p>\n","redirect_url":false,"user_role":[],"enable_restriction_pass":0,"restriction_pass_message":"<p style=\\\"text-align: center;\\\">You don\\'t have permissions for passing the poll<\/p>\n","enable_logged_users":0,"enable_logged_users_message":"<p style=\\\"text-align: center;\\\">You must sign in for passing the poll<\/p>\n","notify_email_on":0,"notify_email":"n.suvorov@robopro.team","result_sort_type":"none","create_date":"2023-12-20 15:41:09","author":{"id":"21","name":"Maks Artemov"},"redirect_after_vote_delay":0,"published":1,"enable_restart_button":0,"show_votes_count":0,"show_res_percent":1,"show_login_form":"off","info_form":0,"fields":"apm_name,apm_email,apm_phone","required_fields":"apm_email","info_form_title":"<h5>Please fill out the form:<\/h5>\n","enable_mailchimp":"off","redirect_after_submit":0,"mailchimp_list":"","users_role":"[]","poll_bg_image_position":"center center","poll_bg_img_in_finish_page":"on","ays_add_post_for_poll":"off","result_in_rgba":"off","show_passed_users":"off","see_result_button":"on","see_result_radio":"ays_see_result_immediately","loader_font_size":"64","effect_message":"","poll_allow_collecting_users_data":"off","poll_every_answer_redirect_delay":"","poll_enable_answer_image_after_voting":"off","poll_enable_answer_redirect_delay":"off","poll_show_passed_users_count":3,"poll_allow_answer":"off","poll_allow_answer_require":"off","poll_answer_image_height":"150","poll_answer_image_height_for_mobile":"150","poll_title_alignment":"left","poll_text_type_length_enable":"off","poll_text_type_limit_type":"characters","poll_text_type_limit_length":"","poll_text_type_limit_message":"off","poll_text_type_placeholder":"Your answer","poll_text_type_width":"","poll_text_type_width_type":"percent","poll_enable_password":"off","poll_password":"","poll_enable_password_visibility":"off","poll_password_message":"Please enter password","display_fields_labels":"off","poll_create_author":"","poll_logo_url_new_tab":"off","enable_social_links":"off","poll_social_links_heading":"","social_links":{"linkedin_link":"","facebook_link":"","twitter_link":"","vkontakte_link":"","youtube_link":""},"show_chart_type":"default_bar_chart","show_chart_type_google_height":400,"answers_grid_column_mobile":"on","poll_enable_animation_top":"on"}';\t\t\t<\/script><\/div><\/form><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Caida_de_las_acciones_de_Pfizer_analisis_de_los_factores_principales\"><\/span><a><\/a>Ca&iacute;da de las acciones de Pfizer: an&aacute;lisis de los factores principales<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Si bien la crisis de la COVID-19 result&oacute; muy perjudicial para las aerol&iacute;neas, impuls&oacute; a muchos representantes del sector farmac&eacute;utico a un nivel nunca visto; entre ellas, a la empresa que protagoniza este art&iacute;culo. Pfizer Inc., en colaboraci&oacute;n con BioNTech SE (NASDAQ: BNTX), desarroll&oacute; una vacuna contra la infecci&oacute;n por coronavirus. A principios de diciembre de 2020, se convirti&oacute; en la primera empresa del mundo en&nbsp;<a href=\"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-achieve-first-authorization-world\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">obtener<\/a>&nbsp;la autorizaci&oacute;n regulatoria para su uso, y posteriormente la suministr&oacute; por casi todo el mundo.<\/p>\n\n\n\n<p>Este desarrollo tuvo un impacto positivo en los ingresos de la compa&ntilde;&iacute;a, que alcanzaron los 12.030 millones de d&oacute;lares seg&uacute;n el&nbsp;<a href=\"https:\/\/s28.q4cdn.com\/781576035\/files\/doc_financials\/2020\/q1\/Q1-2020-PFE-Earnings-Release-(1).pdf\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">informe<\/a>&nbsp;del primer trimestre de 2020, y 25.660 millones de d&oacute;lares seg&uacute;n el&nbsp;<a href=\"https:\/\/s28.q4cdn.com\/781576035\/files\/doc_financials\/2022\/q1\/Q1-2022-PFE-Earnings-Release.pdf\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">informe<\/a>&nbsp;del primer trimestre de 2022.<\/p>\n\n\n\n<p>Sin embargo, cuando otras empresas introdujeron vacunas contra la COVID-19, la demanda del medicamento de Pfizer disminuy&oacute;, lo que afect&oacute; negativamente al estado financiero de la corporaci&oacute;n.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Salud_financiera_de_Pfizer_una_revision_detallada\"><\/span><a><\/a>Salud financiera de Pfizer: una revisi&oacute;n detallada<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>En su&nbsp;<a href=\"https:\/\/s28.q4cdn.com\/781576035\/files\/doc_financials\/2023\/q3\/Q3-2023-PFE-Earnings-Release.pdf\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">informe<\/a>&nbsp;del tercer trimestre de 2023, publicado el 31 de octubre, Pfizer Inc. anunci&oacute; que:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Los ingresos disminuyeron un 41,55%, hasta los 13.230 millones de d&oacute;lares<\/li>\n\n\n\n<li>Las p&eacute;rdidas netas fueron de 2380 millones de d&oacute;lares o 0,42 d&oacute;lares por acci&oacute;n; mientras que, hace un a&ntilde;o, el beneficio neto alcanz&oacute; los 8610 millones de d&oacute;lares o 1,54 d&oacute;lares por acci&oacute;n<\/li>\n\n\n\n<li>Los ingresos por vacunas contra la COVID-19 cayeron un 70% hasta los 1310 millones de d&oacute;lares<\/li>\n\n\n\n<li>Los ingresos por productos no relacionados con el COVID-19 aumentaron un 10%<\/li>\n\n\n\n<li>Hasta finales de 2024 se prev&eacute;n despidos de personal y recortes de costes por valor de 3500 millones de d&oacute;lares<\/li>\n<\/ul>\n\n\n\n<p>Las p&eacute;rdidas de julio a septiembre de 2023 fueron un r&eacute;cord para el gigante farmac&eacute;utico: la mayor p&eacute;rdida trimestral hasta entonces hab&iacute;a sido de 580 millones de d&oacute;lares, registrada en el cuarto trimestre de 2019. La direcci&oacute;n de la empresa atribuye esto a p&eacute;rdidas en el inventario frente al COVID-19 por valor de 5600 millones de d&oacute;lares.<br>Un factor negativo adicional es un fuerte aumento de la carga de deuda en el tercer trimestre de 2023 de m&aacute;s del 87%, hasta los 61.000 millones de d&oacute;lares, impulsada por la emisi&oacute;n de bonos por 31.000 millones de d&oacute;lares para financiar la compra de Seagen Inc. Sin embargo, es importante se&ntilde;alar que incluso con el aumento de la deuda, la relaci&oacute;n deuda-capital se sit&uacute;a en 0,66.<\/p>\n\n\n\n<div class=\"block-banner\">\n    <div class=\"block-banner__content\">\n      <div class=\"block-banner__text-content\">\n        <p class=\"block-banner__title\">Mejore su trading con <span class=\"nowrap\">R StocksTrader<span><\/span><\/span><\/p>\n        <p class=\"block-banner__text\">&iexcl;Obtenga acceso a m&aacute;s de 12.000 instrumentos con una sola cuenta!<\/p>\n      <\/div>\n    <div class=\"block-banner__images-wrapper\">\n      <img decoding=\"async\" class=\"block-banner__image block-banner__image_mobile\" src=\"\/wp-content\/uploads\/2023\/09\/rst-mobile.png\" alt=\"partner-programme\">\n    <\/div>\n      <a href=\"https:\/\/my.roboforex.com\/es\/register\/rtrader\" class=\"block-banner__button\" target=\"_blank\" rel=\"noopener nofollow\">Comenzar a operar<\/a>\n    <\/div>\n    <div class=\"block-banner__images-wrapper\">\n      <img decoding=\"async\" class=\"block-banner__image block-banner__image_desktop\" src=\"\/wp-content\/uploads\/2023\/09\/rst-desktop.png\" alt=\"partner-programme\">\n    <\/div>\n  <\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Una_mirada_en_profundidad_al_impacto_fallido_del_farmaco_de_perdida_de_peso_de_Pfizer\"><\/span><a><\/a>Una mirada en profundidad al impacto fallido del f&aacute;rmaco de p&eacute;rdida de peso de Pfizer<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Seg&uacute;n&nbsp;<a href=\"https:\/\/datahorizzonresearch.com\/weight-loss-drugs-market-2444\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">DataHorizzon Research<\/a>, el tama&ntilde;o del mercado de medicamentos para bajar de peso se valor&oacute; en 1900 millones de d&oacute;lares en 2022, y se prev&eacute; que alcance los 82.800 millones de d&oacute;lares en 2032. Pfizer Inc. ten&iacute;a la intenci&oacute;n de ingresar a este mercado con sus medicamentos lotiglipron y danuglipron. Se estaban desarrollando dos tipos de danuglipron, con ingestas de una y dos veces al d&iacute;a.<\/p>\n\n\n\n<p>El 26 de junio de 2023, la corporaci&oacute;n&nbsp;<a href=\"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-provides-update-glp-1-ra-clinical-development\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">anunci&oacute;<\/a>&nbsp;que hab&iacute;a interrumpido el desarrollo de lotiglipron debido a su posible efecto negativo en el h&iacute;gado de los pacientes. Cabe destacar que el comienzo de su desarrollo se remonta a 2018.<\/p>\n\n\n\n<p>Los ensayos de Danuglipron&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34127852\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">comenzaron<\/a>&nbsp;en 2021; el medicamento arroj&oacute; resultados prometedores durante los ensayos de fase dos y alcanz&oacute; la misma eficacia que Ozempic, un f&aacute;rmaco popular de Novo Nordisk A\/S (NYSE: NVO). Sin embargo, el 1 de diciembre de 2023, la empresa&nbsp;<a href=\"https:\/\/investors.pfizer.com\/Investors\/News\/news-details\/2023\/Pfizer-Announces-Topline-Phase-2b-Results-of-Oral-GLP-1R-Agonist-Danuglipron-in-Adults-with-Obesity\/default.aspx\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">anunci&oacute;<\/a>&nbsp;que hab&iacute;a cancelado los ensayos cl&iacute;nicos de danuglipron administrado dos veces al d&iacute;a debido a fuertes efectos secundarios como n&aacute;useas, v&oacute;mitos y diarrea. Al mismo tiempo, la empresa continu&oacute; los estudios del segundo tipo de danuglipr&oacute;n.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"El_crecimiento_de_Pfizer_tras_la_adquisicion_de_Seagen_activos_y_oportunidades\"><\/span><a><\/a>El crecimiento de Pfizer tras la adquisici&oacute;n de Seagen: activos y oportunidades<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El 13 de marzo de 2023, Pfizer Inc.&nbsp;<a href=\"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-invests-43-billion-battle-cancer\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">anunci&oacute;<\/a>&nbsp;la adquisici&oacute;n de la empresa estadounidense de biotecnolog&iacute;a Seagen Inc., especializada en el desarrollo de medicamentos para el tratamiento del c&aacute;ncer, por casi 43.000 millones de d&oacute;lares. Ya el 14 de diciembre, las partes&nbsp;<a href=\"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-completes-acquisition-seagen\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">informaron<\/a>&nbsp;de la finalizaci&oacute;n del acuerdo.<\/p>\n\n\n\n<p>La adquisici&oacute;n de Seagen Inc. ha proporcionado a Pfizer Inc. acceso a cuatro medicamentos para tratar varios tipos de c&aacute;ncer, ya aprobados por los reguladores y disponibles para la venta; es probable que esto fortalezca su posici&oacute;n en este mercado. Esta es la lista de dichos medicamentos:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ADCETRIS (linfoma): aprobado en m&aacute;s de 70 pa&iacute;ses<\/li>\n\n\n\n<li>RADCEV (carcinoma): aprobado en EEUU, la UE, Canad&aacute;, Australia, Jap&oacute;n y Corea del Sur<\/li>\n\n\n\n<li>Tivdak (c&aacute;ncer de cuello uterino recurrente o metast&aacute;sico): aprobado en EEUU y la UE<\/li>\n\n\n\n<li>TUKYSA (c&aacute;ncer de mama irresecable o metast&aacute;sico): aprobado en EEUU, Canad&aacute;, la UE, Australia, Singapur y otros pa&iacute;ses.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Futuro_de_Pfizer_medicamentos_prometedores_en_la_casilla_de_salida\"><\/span><a><\/a>Futuro de Pfizer: medicamentos prometedores en la casilla de salida<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Seg&uacute;n&nbsp;<a href=\"https:\/\/cdn.pfizer.com\/pfizercom\/product-pipeline\/Pipeline_Update_31OCT2023_0.pdf?VersionId=3IauakagDODRg9iQQ5U0P7JG5E_8jJ9h\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">datos<\/a>&nbsp;de Pfizer Inc., a 31 de octubre de 2023, la empresa tiene 83 medicamentos en tr&aacute;mite, 26 en estudios de etapa uno, 30 en etapa dos, 23 en etapa tres y cuatro bajo <a href=\"https:\/\/my.roboforex.com\/es\/register\/\" data-internallinksmanager029f6b8e52c=\"200\" title=\"Cuenta\">registro<\/a>. Estos medicamentos se clasifican en seis grupos: enfermedades raras\/hematolog&iacute;a no maligna, antiinfecciosos, inflamaci&oacute;n e inmunolog&iacute;a, medicina interna, vacunas y oncolog&iacute;a.<\/p>\n\n\n\n<p>La oncolog&iacute;a es el grupo m&aacute;s grande por el n&uacute;mero de medicamentos estudiados: 27, doce en la etapa uno, cinco en la segunda etapa, nueve en la tercera etapa y uno en proceso de registro.<\/p>\n\n\n\n<p>Pfizer Inc. se encuentra investigando los medicamentos anuglipron y PF-06954522 para mejorar sus perspectivas en el mercado de medicamentos para bajar de peso.<\/p>\n\n\n\n<p>Vale la pena se&ntilde;alar que fidanacogene elaparvovec, que se encuentra en la etapa de registro, recibi&oacute; una&nbsp;<a href=\"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/fda-accepts-pfizers-application-hemophilia-b-gene-therapy\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">designaci&oacute;n<\/a>&nbsp;de medicamento innovador por parte de la Administraci&oacute;n de Alimentos y Medicamentos (FDA, por sus siglas en ingl&eacute;s) de EEUU.<\/p>\n\n\n\n<div class=\"block-banner violet-dark_blue\">\n    <div class=\"block-banner__content\">\n      <div class=\"block-banner__text-content\">\n        <p class=\"block-banner__title\">&iquest;Le falta tiempo para operar en toda regla?<\/p>\n        <p class=\"block-banner__text\">&iexcl;Comience a copiar las estrategias de trading de los operadores de mayor rango en CopyFX ahora mismo!<\/p>\n      <\/div>\n    <div class=\"block-banner__images-wrapper\">\n      <img decoding=\"async\" class=\"block-banner__image block-banner__image_mobile\" src=\"\/wp-content\/uploads\/2023\/09\/copyfx1-mobile.png\" alt=\"partner-programme\">\n    <\/div>\n      <a href=\"https:\/\/my.roboforex.com\/es\/register\/\" class=\"block-banner__button\" target=\"_blank\" rel=\"noopener nofollow\">Empezar a invertir<\/a>\n    <\/div>\n    <div class=\"block-banner__images-wrapper\">\n      <img decoding=\"async\" class=\"block-banner__image block-banner__image_desktop\" src=\"\/wp-content\/uploads\/2023\/09\/copyfx1-desktop.png\" alt=\"partner-programme\">\n    <\/div>\n  <\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Historico_de_los_dividendos_y_retornos_de_los_inversores_en_Pfizer\"><\/span><a><\/a>Hist&oacute;rico de los dividendos y retornos de los inversores en Pfizer<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Pfizer Inc. lleva m&aacute;s de 20 a&ntilde;os pagando dividendos a sus accionistas. El rendimiento fue del 8,53% en abril de 2009, con una deflaci&oacute;n en EEUU del 2,1%; y alcanz&oacute; el 9,47% en enero de 2021, con una inflaci&oacute;n del 1,4% en el pa&iacute;s americano. En diciembre de 2023, la rentabilidad por dividendo se situ&oacute; en el 5,42%, con una inflaci&oacute;n del 3,1%. Como podemos ver, la corporaci&oacute;n pretende pagar dividendos superiores a la tasa de inflaci&oacute;n.<br>A pesar de que el tercer trimestre de 2023 gener&oacute; p&eacute;rdidas, el consejo de administraci&oacute;n aprob&oacute; un pago de dividendos de 0,41 d&oacute;lares por acci&oacute;n, y&nbsp;<a href=\"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-declares-first-quarter-2024-dividend\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">planea<\/a>&nbsp;aumentar el dividendo del primer trimestre de 2024 a 0,42 d&oacute;lares por acci&oacute;n.<br>En funci&oacute;n de los resultados financieros, el gigante farmac&eacute;utico recompra ocasionalmente sus acciones. Seg&uacute;n&nbsp;<a href=\"https:\/\/www.financecharts.com\/stocks\/PFE\/cash-flow\/repurchase-of-capital-stock\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Finance Charts<\/a>, la &uacute;ltima ocasi&oacute;n tuvo lugar en el primer trimestre de 2022, cuando la empresa recompr&oacute; acciones por valor de 2000 millones de d&oacute;lares.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Tendencias_actuales_en_las_acciones_de_Pfizer_resumen_analitico\"><\/span><a><\/a>Tendencias actuales en las acciones de Pfizer: resumen anal&iacute;tico<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>En marzo de 2013, las acciones de Pfizer Inc. superaron el nivel de resistencia de 26,50 d&oacute;lares, que luego se convirti&oacute; en nivel de soporte. Desde entonces, las acciones han puesto a prueba esta marca seis veces, pero no han podido superarla. El 13 de diciembre de 2023, las cotizaciones volvieron a caer hasta el soporte de 26,50 USD.<\/p>\n\n\n\n<p>Un fuerte aumento en el volumen de trading de acciones puede sugerir que los inversores han comenzado a interesarse por ellas. En esta situaci&oacute;n, es probable que el precio se recupere del nivel de soporte y suba hasta la resistencia m&aacute;s cercana de 33,00 USD.<\/p>\n\n\n\n<!-- TradingView Chart BEGIN -->\n<script type=\"text\/javascript\" src=\"https:\/\/s3.tradingview.com\/tv.js\"><\/script>\n<script type=\"text\/javascript\">\nvar tradingview_embed_options = {};\ntradingview_embed_options.width = '790';\ntradingview_embed_options.height = '475';\ntradingview_embed_options.chart = '2FMOg6e6';\nnew TradingView.chart(tradingview_embed_options);\n<\/script>\n<p><a href=\"https:\/\/www.tradingview.com\/chart\/PFE\/2FMOg6e6-Technical-analysis-of-Pfizer-stock\/\" rel=\"nofollow\"> <\/a> <em>Gr&aacute;fico de acciones de Pfizer Inc.*<\/em><\/p>\n<!-- TradingView Chart END -->\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Predicciones_de_los_expertos_la_trayectoria_futura_de_las_acciones_de_Pfizer\"><\/span><a><\/a>Predicciones de los expertos: la trayectoria futura de las acciones de Pfizer<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Seg&uacute;n&nbsp;<a href=\"https:\/\/www.barchart.com\/stocks\/quotes\/PFE\/analyst-ratings\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Barchart<\/a>, seis de diecis&eacute;is analistas calificaron las acciones de Pfizer Inc. como Compra Fuerte, uno como Compra Moderada y nueve como Mantener, con un precio objetivo promedio de 37,19 USD<\/li>\n\n\n\n<li>Seg&uacute;n los datos de&nbsp;<a href=\"https:\/\/www.marketbeat.com\/stocks\/NYSE\/PFE\/price-target\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">MarketBeat<\/a>, cinco de diecis&eacute;is expertos asignaron una calificaci&oacute;n de Compra a estas acciones, mientras que once designaron una calificaci&oacute;n de Mantener, con un precio objetivo promedio de 40,35 USD<\/li>\n\n\n\n<li>Seg&uacute;n&nbsp;<a href=\"https:\/\/www.tipranks.com\/stocks\/pfe\/forecast\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">TipRanks<\/a>, seis de quince analistas otorgaron una calificaci&oacute;n de Compra a las acciones de Pfizer Inc., y nueve las calificaron como Mantener. El precio objetivo promedio es 34,25 USD<\/li>\n\n\n\n<li>Seg&uacute;n informaci&oacute;n de&nbsp;<a href=\"https:\/\/stockanalysis.com\/stocks\/pfe\/forecast\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Stock Analysis<\/a>, tres de diecis&eacute;is especialistas asignaron a las acciones una calificaci&oacute;n de Compra Fuerte, dos dieron una recomendaci&oacute;n de Compra y once designaron una calificaci&oacute;n de Mantener. La previsi&oacute;n de precio burs&aacute;til promedio a doce meses es de 40,38 USD<\/li>\n\n\n\n<li>Los expertos de&nbsp;<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nyse-pfe\/pfizer\/future\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Simply Wall St<\/a>&nbsp;predicen que los ingresos y el beneficio neto de la corporaci&oacute;n farmac&eacute;utica aumentar&aacute;n un 0,5% y un 12,5% anual, respectivamente. Se espera que la rentabilidad sobre el capital alcance el 15,4% en tres a&ntilde;os<\/li>\n<\/ul>\n\n\n\n<p>Dada la informaci&oacute;n anterior, cabe se&ntilde;alar que ninguno de los expertos que cubren las acciones de Pfizer Inc. recomienda vender sus acciones. El 18 de diciembre de 2023, el valor de la acci&oacute;n alcanz&oacute; los 26,63 d&oacute;lares, con un precio objetivo medio que oscilaba entre 34,25 y 40,35 d&oacute;lares.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><a><\/a>Conclusi&oacute;n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Despu&eacute;s de examinar detenidamente las operaciones de Pfizer Inc. durante los &uacute;ltimos a&ntilde;os, se puede suponer que se espera una disminuci&oacute;n en las ganancias de la empresa. La vacuna COVID-19 permiti&oacute; a la corporaci&oacute;n sacar provecho de la pandemia. Hoy en d&iacute;a, con una disminuci&oacute;n en el n&uacute;mero de casos de coronavirus a nivel mundial y una demanda significativamente menor de la vacuna, los ingresos por la venta de este medicamento han disminuido.<\/p>\n\n\n\n<p>Sin embargo, la tendencia positiva persiste: mientras que los ingresos del primer al tercer trimestre de 2019 ascendieron a 39.050 millones de d&oacute;lares, estos alcanzaron los 44.240 millones de d&oacute;lares en el mismo per&iacute;odo de 2023. Adem&aacute;s, los ingresos procedentes de productos distintos de la vacuna del COVID-19 crecen de manera gradual, y la empresa apunta a despidos de personal y recortes de costos.<\/p>\n\n\n\n<p>En base a lo anterior, se puede suponer que, en t&eacute;rminos de sus precios actuales, las acciones de Pfizer Inc. parecen atractivas para inversiones a largo plazo que busquen cobrar dividendos.<br>A la vez, el hist&oacute;rico muestra que las inversiones en la empresa destinadas a beneficiarse del crecimiento del valor de las acciones a largo plazo pueden no materializarse. Por ejemplo, si los inversores hubieran comprado sus acciones en 2013, estas no hubiesen ofrecido rentabilidad alguna en diciembre de 2023.<\/p>\n\n\n\n<p class=\"wp-block-button aligncenter\">\n<a class=\"button button-green\" href=\"https:\/\/my.roboforex.com\/es\/register\/\" rel=\"nofollow\">Abrir cuenta<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\">\n\n\n\n<p><em>* &ndash;&nbsp;La plataforma TradingView proporciona los gr&aacute;ficos de este art&iacute;culo, con una amplia gama de herramientas para analizar los <a href=\"https:\/\/roboforex.com\/es\/investments\/investment-platforms\/copyfx-service\/\" data-internallinksmanager029f6b8e52c=\"49\" title=\"plataforma de inversi\u00f3n\">mercados financieros<\/a>. Se trata de un c&oacute;modo servicio de gr&aacute;ficos de datos de mercado en l&iacute;nea de alta tecnolog&iacute;a que permite a los usuarios realizar an&aacute;lisis t&eacute;cnicos, investigar datos financieros y comunicarse con otros operadores e inversores. Adem&aacute;s, ofrece una valiosa orientaci&oacute;n sobre c&oacute;mo leer el <a href=\"https:\/\/roboforex.com\/es\/beginners\/analytics\/economic-calendar\/\" data-internallinksmanager029f6b8e52c=\"2\" title=\"calendario econ\u00f3mico\">calendario econ&oacute;mico<\/a> de <a href=\"https:\/\/roboforex.com\/es\/\" data-internallinksmanager029f6b8e52c=\"1\" title=\"br\u00f3ker de forex\">Forex<\/a>, junto con informaci&oacute;n sobre <a href=\"https:\/\/www.tradingview.com\/symbols\/CBOT_MINI-YM1!\/\" rel=\"nofollow\">la herramienta Dow Futures<\/a>.<\/em><\/p>\n<\/body><\/html>\n","protected":false},"excerpt":{"rendered":"<p>Descubre la \u00faltima previsi\u00f3n burs\u00e1til de Pfizer. Lea el an\u00e1lisis t\u00e9cnico y fundamental de PFE. Eche un vistazo a una gr\u00e1fica burs\u00e1til en vivo de Pfizer.<\/p>\n","protected":false},"author":22,"featured_media":17673,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2],"tags":[33],"class_list":["post-17655","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","tag-pfizer-inc"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Previsi\u00f3n burs\u00e1til de Pfizer \u2013 An\u00e1lisis t\u00e9cnico de PFE<\/title>\n<meta name=\"description\" content=\"Descubre la \u00faltima previsi\u00f3n burs\u00e1til de Pfizer. Lea el an\u00e1lisis t\u00e9cnico y fundamental de PFE. Eche un vistazo a una gr\u00e1fica burs\u00e1til en vivo de Pfizer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Previsi\u00f3n burs\u00e1til de Pfizer \u2013 An\u00e1lisis t\u00e9cnico de PFE\" \/>\n<meta property=\"og:description\" content=\"Descubre la \u00faltima previsi\u00f3n burs\u00e1til de Pfizer. Lea el an\u00e1lisis t\u00e9cnico y fundamental de PFE. Eche un vistazo a una gr\u00e1fica burs\u00e1til en vivo de Pfizer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/\" \/>\n<meta property=\"og:site_name\" content=\"R Blog ES - RoboForex\" \/>\n<meta property=\"og:image\" content=\"https:\/\/roboforex.com\/blog\/wp-content\/uploads\/sites\/11\/2023\/12\/20.12.2023.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1856\" \/>\n\t<meta property=\"og:image:height\" content=\"1044\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Eugene Savitsky\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/\"},\"headline\":\"An\u00e1lisis de las acciones de Pfizer: Tras una ca\u00edda del 50% en dos a\u00f1os: \u00bfes este el momento de invertir?\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/\"},\"wordCount\":1993,\"publisher\":{\"@id\":\"https:\/\/roboforex.com\/es\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/roboforex.com\/es\/blog\/wp-content\/uploads\/sites\/11\/2023\/12\/20.12.2023.jpg\",\"keywords\":[\"pfizer inc\"],\"articleSection\":[\"An\u00e1lisis\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/\",\"url\":\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/\",\"name\":\"Previsi\u00f3n burs\u00e1til de Pfizer \u2013 An\u00e1lisis t\u00e9cnico de PFE\",\"isPartOf\":{\"@id\":\"https:\/\/roboforex.com\/es\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/roboforex.com\/es\/blog\/wp-content\/uploads\/sites\/11\/2023\/12\/20.12.2023.jpg\",\"description\":\"Descubre la \u00faltima previsi\u00f3n burs\u00e1til de Pfizer. Lea el an\u00e1lisis t\u00e9cnico y fundamental de PFE. Eche un vistazo a una gr\u00e1fica burs\u00e1til en vivo de Pfizer.\",\"breadcrumb\":{\"@id\":\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#primaryimage\",\"url\":\"https:\/\/roboforex.com\/es\/blog\/wp-content\/uploads\/sites\/11\/2023\/12\/20.12.2023.jpg\",\"contentUrl\":\"https:\/\/roboforex.com\/es\/blog\/wp-content\/uploads\/sites\/11\/2023\/12\/20.12.2023.jpg\",\"width\":1856,\"height\":1044,\"caption\":\"An\u00e1lisis de las acciones de Pfizer: Tras una ca\u00edda del 50% en dos a\u00f1os: \u00bfes este el momento de invertir?\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Principales\",\"item\":\"https:\/\/roboforex.com\/es\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"An\u00e1lisis\",\"item\":\"https:\/\/roboforex.com\/es\/blog\/blog\/category\/analysis\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"An\u00e1lisis de las acciones de Pfizer: Tras una ca\u00edda del 50% en dos a\u00f1os: \u00bfes este el momento de invertir?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/roboforex.com\/es\/blog\/#website\",\"url\":\"https:\/\/roboforex.com\/es\/blog\/\",\"name\":\"R Blog ES - RoboForex\",\"description\":\"Blog RoboForex para traders: Noticias de trading, An\u00e1lisis, Pron\u00f3sticos - forex y acciones | R-Blog\",\"publisher\":{\"@id\":\"https:\/\/roboforex.com\/es\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/roboforex.com\/es\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/roboforex.com\/es\/blog\/#organization\",\"name\":\"RoboForex Ltd\",\"url\":\"https:\/\/roboforex.com\/es\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/roboforex.com\/es\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/roboforex.com\/blog\/wp-content\/uploads\/sites\/11\/2018\/10\/rf-logo_square.png\",\"contentUrl\":\"https:\/\/roboforex.com\/blog\/wp-content\/uploads\/sites\/11\/2018\/10\/rf-logo_square.png\",\"width\":512,\"height\":512,\"caption\":\"RoboForex Ltd\"},\"image\":{\"@id\":\"https:\/\/roboforex.com\/es\/blog\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Previsi\u00f3n burs\u00e1til de Pfizer \u2013 An\u00e1lisis t\u00e9cnico de PFE","description":"Descubre la \u00faltima previsi\u00f3n burs\u00e1til de Pfizer. Lea el an\u00e1lisis t\u00e9cnico y fundamental de PFE. Eche un vistazo a una gr\u00e1fica burs\u00e1til en vivo de Pfizer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/","og_locale":"es_ES","og_type":"article","og_title":"Previsi\u00f3n burs\u00e1til de Pfizer \u2013 An\u00e1lisis t\u00e9cnico de PFE","og_description":"Descubre la \u00faltima previsi\u00f3n burs\u00e1til de Pfizer. Lea el an\u00e1lisis t\u00e9cnico y fundamental de PFE. Eche un vistazo a una gr\u00e1fica burs\u00e1til en vivo de Pfizer.","og_url":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/","og_site_name":"R Blog ES - RoboForex","og_image":[{"width":1856,"height":1044,"url":"https:\/\/roboforex.com\/blog\/wp-content\/uploads\/sites\/11\/2023\/12\/20.12.2023.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Eugene Savitsky","Tiempo de lectura":"10 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#article","isPartOf":{"@id":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/"},"headline":"An\u00e1lisis de las acciones de Pfizer: Tras una ca\u00edda del 50% en dos a\u00f1os: \u00bfes este el momento de invertir?","mainEntityOfPage":{"@id":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/"},"wordCount":1993,"publisher":{"@id":"https:\/\/roboforex.com\/es\/blog\/#organization"},"image":{"@id":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#primaryimage"},"thumbnailUrl":"https:\/\/roboforex.com\/es\/blog\/wp-content\/uploads\/sites\/11\/2023\/12\/20.12.2023.jpg","keywords":["pfizer inc"],"articleSection":["An\u00e1lisis"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/","url":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/","name":"Previsi\u00f3n burs\u00e1til de Pfizer \u2013 An\u00e1lisis t\u00e9cnico de PFE","isPartOf":{"@id":"https:\/\/roboforex.com\/es\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#primaryimage"},"image":{"@id":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#primaryimage"},"thumbnailUrl":"https:\/\/roboforex.com\/es\/blog\/wp-content\/uploads\/sites\/11\/2023\/12\/20.12.2023.jpg","description":"Descubre la \u00faltima previsi\u00f3n burs\u00e1til de Pfizer. Lea el an\u00e1lisis t\u00e9cnico y fundamental de PFE. Eche un vistazo a una gr\u00e1fica burs\u00e1til en vivo de Pfizer.","breadcrumb":{"@id":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#primaryimage","url":"https:\/\/roboforex.com\/es\/blog\/wp-content\/uploads\/sites\/11\/2023\/12\/20.12.2023.jpg","contentUrl":"https:\/\/roboforex.com\/es\/blog\/wp-content\/uploads\/sites\/11\/2023\/12\/20.12.2023.jpg","width":1856,"height":1044,"caption":"An\u00e1lisis de las acciones de Pfizer: Tras una ca\u00edda del 50% en dos a\u00f1os: \u00bfes este el momento de invertir?"},{"@type":"BreadcrumbList","@id":"https:\/\/roboforex.com\/es\/blog\/blog\/2023\/12\/20\/analisis-de-las-acciones-de-pfizer-tras-una-caida-del-50-en-dos-anos-es-este-el-momento-de-invertir\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Principales","item":"https:\/\/roboforex.com\/es\/blog\/"},{"@type":"ListItem","position":2,"name":"An\u00e1lisis","item":"https:\/\/roboforex.com\/es\/blog\/blog\/category\/analysis\/"},{"@type":"ListItem","position":3,"name":"An\u00e1lisis de las acciones de Pfizer: Tras una ca\u00edda del 50% en dos a\u00f1os: \u00bfes este el momento de invertir?"}]},{"@type":"WebSite","@id":"https:\/\/roboforex.com\/es\/blog\/#website","url":"https:\/\/roboforex.com\/es\/blog\/","name":"R Blog ES - RoboForex","description":"Blog RoboForex para traders: Noticias de trading, An\u00e1lisis, Pron\u00f3sticos - forex y acciones | R-Blog","publisher":{"@id":"https:\/\/roboforex.com\/es\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/roboforex.com\/es\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/roboforex.com\/es\/blog\/#organization","name":"RoboForex Ltd","url":"https:\/\/roboforex.com\/es\/blog\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/roboforex.com\/es\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/roboforex.com\/blog\/wp-content\/uploads\/sites\/11\/2018\/10\/rf-logo_square.png","contentUrl":"https:\/\/roboforex.com\/blog\/wp-content\/uploads\/sites\/11\/2018\/10\/rf-logo_square.png","width":512,"height":512,"caption":"RoboForex Ltd"},"image":{"@id":"https:\/\/roboforex.com\/es\/blog\/#\/schema\/logo\/image\/"}}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/roboforex.com\/es\/blog\/wp-content\/uploads\/sites\/11\/2023\/12\/20.12.2023.jpg","views":"","_links":{"self":[{"href":"https:\/\/roboforex.com\/es\/blog\/wp-json\/wp\/v2\/posts\/17655"}],"collection":[{"href":"https:\/\/roboforex.com\/es\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/roboforex.com\/es\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/roboforex.com\/es\/blog\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/roboforex.com\/es\/blog\/wp-json\/wp\/v2\/comments?post=17655"}],"version-history":[{"count":4,"href":"https:\/\/roboforex.com\/es\/blog\/wp-json\/wp\/v2\/posts\/17655\/revisions"}],"predecessor-version":[{"id":18082,"href":"https:\/\/roboforex.com\/es\/blog\/wp-json\/wp\/v2\/posts\/17655\/revisions\/18082"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/roboforex.com\/es\/blog\/wp-json\/wp\/v2\/media\/17673"}],"wp:attachment":[{"href":"https:\/\/roboforex.com\/es\/blog\/wp-json\/wp\/v2\/media?parent=17655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/roboforex.com\/es\/blog\/wp-json\/wp\/v2\/categories?post=17655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/roboforex.com\/es\/blog\/wp-json\/wp\/v2\/tags?post=17655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}